Artificial intelligence is almost twice as accurate as a biopsy(活组织检查) at judging the aggressiveness of some cancers, experts say. Cancer kills 10 million people globally every year, according to the WHO. But for patients the disease can be prevented if detected instantly and dealt with quickly.

A recent study suggested an AI algorithm (算法) was far better than a biopsy at correctly grading the aggressiveness of sarcomas ( 肉 瘤 ), a rare form of cancer. Researchers hope AI will improve outcomes for patients by giving doctors a more accurate way of grading tumours (肿瘤). Because high-grade tumours can indicate aggressive disease, the tool could help ensure those high-risk patients are identified more quickly and treated instantly. Low-risk patients could also be spared unnecessary treatments, follow-up scans and hospital visits.

Researchers say the algorithm could be applied to other types of cancer in future. The team specifically looked at retroperitoneal sarcomas, which develop at the back of the abdomen and are difficult to diagnose(诊断) and treat due to their location. They used CT scans from 170 patients with the two most common forms of retroperitoneal sarcoma——leiomyosarcoma and liposarcoma. Using data from these scans they created an AI algorithm, which was then tested on 89 patients in other countries. In grading how aggressive the tumour was, the technology was accurate in 82% of the cases, while biopsies were 44%.

AI could also recognize leiomyosarcoma and liposarcoma in 84% of sarcomas tested, while radiologists were able to identify them in 65% of the cases. Christina Messiou, the study leader, said: "We're incredibly excited by the potential of this state-of-the-art

technology, which could lead to patients having better outcomes through faster diagnosis. As patients with retroperitoneal sarcoma are routinely scanned with CT, we hope this tool will eventually be used globally, ensuring that not just specialist centres can reliably identify and grade the disease."

Richard Davison, chief executive of Sarcoma UK, said the results looked "very promising". He added: "People are more likely to survive sarcoma if diagnosed early. One in six people with sarcoma cancer wait more than a year to receive an accurate diagnosis, so any research that helps patients receive better treatment and support is welcome."